0000939798-17-000100.txt : 20171201
0000939798-17-000100.hdr.sgml : 20171201
20171201172539
ACCESSION NUMBER: 0000939798-17-000100
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170901
FILED AS OF DATE: 20171201
DATE AS OF CHANGE: 20171201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clarence-Smith Kathleen
CENTRAL INDEX KEY: 0001721625
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 171234986
MAIL ADDRESS:
STREET 1: 1623 31ST STREET NW
CITY: WASHINGTON
STATE: DC
ZIP: 20007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 1825 K STREET
STREET 2: SUITE 510
CITY: WASHINGTON, D.C.
STATE: DC
ZIP: 33602
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2017-09-01
0
0000109657
GT Biopharma, Inc.
GTBP
0001721625
Clarence-Smith Kathleen
1825 K STREET, SUITE 510
WASHINGTON
DC
20006
1
1
1
0
CEO
common stock
8505633
D
/s/ Kathleen Clarence-Smith
2017-12-01